Elevance Health, Inc. vs Pfizer, Inc. — Stock Comparison
Elevance Health, Inc. (ELV) and Pfizer, Inc. (PFE) are both listed on US exchanges. This page compares their Q·Score ratings, key fundamentals (P/E, margins, growth), and Wall Street analyst consensus side by side. Data sourced from Yahoo Finance and updated on each page load.
Pfizer, Inc. narrowly edges Elevance Health, Inc. on Q·Score (6.2 vs 5.9 out of 10), led by Growth (5.1 vs 3.9) and Quality (6.4 vs 5.9). Elevance Health, Inc. scores higher on Sentiment, reflecting stronger analyst and market sentiment. Analyst consensus targets imply greater upside for PFE (+13.6%) than for ELV (-2.0%).
Price Performance
Normalised to 100 at period start — shows relative performance.
Q·Score Breakdown
64% of 22 covering analysts have a positive rating.
⚠ earnings contracting 17% year-over-year.
Consistently beats earnings estimates (4/4 quarters).
⚠ earnings contracting 10% year-over-year.
Analyst Consensus
Fundamentals
Frequently Asked Questions
ELV vs PFE: which stock scores better overall?
Based on Q·Score, Pfizer, Inc. (PFE) scores 6.2/10 versus Elevance Health, Inc. (ELV) at 5.9/10. The Q·Score measures five dimensions: Quality, Health, Growth, Valuation, and Sentiment. For informational purposes only — not financial advice.
Which has better revenue growth: ELV or PFE?
Pfizer, Inc. (PFE) scores higher on Growth (5.1/10 vs 3.9/10). Elevance Health, Inc. reports revenue growth (2.6% YoY) while Pfizer, Inc. reports (5.4% YoY). Growth scores reflect revenue and earnings momentum relative to sector peers.
Is ELV or PFE more attractively valued?
Pfizer, Inc. (PFE) scores higher on Valuation (7/10 vs 6.5/10). ELV trades at 14.5× P/E versus PFE at 9.1×. Valuation is assessed using P/E ratio, analyst price targets, and 52-week range positioning relative to sector peers.
What do analysts say about ELV vs PFE?
There are 21 analysts covering ELV with a consensus price target of $415.81, and 27 analysts covering PFE with a consensus target of $29.19. Analyst consensus ratings are aggregated from Wall Street research and do not constitute investment advice.
Which is more profitable: ELV or PFE?
Pfizer, Inc. (PFE) scores higher on Quality (6.4/10 vs 5.9/10). Net profit margin: ELV at 2.6%, PFE at 11.8%. Quality scores reflect profit margins, return on equity, and free cash flow generation.
Which has stronger financial health: ELV or PFE?
Pfizer, Inc. (PFE) scores higher on Financial Health (7/10 vs 6.5/10). Market beta: ELV at 0.68, PFE at 0.29. Health scores consider beta, debt-to-equity, and current ratio. All investments carry risk — this is not investment advice.
What are the market caps of ELV and PFE?
Elevance Health, Inc. (ELV) has a market capitalisation of $92.2B, while Pfizer, Inc. (PFE) has a market cap of $146.5B. Market cap data is sourced from Yahoo Finance and reflects the most recent available figures.
Do ELV or PFE pay dividends?
ELV pays a dividend yield of 1.62%, while PFE pays a dividend yield of 6.69%. Dividend yields fluctuate with share price and company payout decisions.
Related Comparisons
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →